Evidence map›Paper›PMID 39205168›Full record

ArticleViruses2024

Updating and Refining of Economic Evaluation of Rotavirus Vaccination in Spain: A Cost-Utility and Budget Impact Analysis.

Iñaki Imaz-Iglesia, Montserrat Carmona, Esther E García-Carpintero, Lucía Pedrosa-Pérez, Alejandro Martínez-Portillo, Enrique Alcalde-Cabero, Renata Linertová, Lidia García-Pérez

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iñaki Imaz-IglesiaNational Health School, Carlos III Institute of Health (Instituto de Salud Carlos III), 28029 Madrid, Spain.ORCID 0000-0002-7864-4194
Montserrat CarmonaChronicity, Primary Healthcare and Health Promotion Research Network (Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 28029 Madrid, Spain.ORCID 0000-0002-4680-7745
Esther E García-CarpinteroChronicity, Primary Healthcare and Health Promotion Research Network (Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 28029 Madrid, Spain.
Lucía Pedrosa-PérezHealth Technology Assessment Agency, Carlos III Institute of Health (Instituto de Salud Carlos III), 28029 Madrid, Spain.
Alejandro Martínez-PortilloNational Health School, Carlos III Institute of Health (Instituto de Salud Carlos III), 28029 Madrid, Spain.
Enrique Alcalde-CaberoNational Centre of Epidemiology, Carlos III Institute of Health (Instituto de Salud Carlos III), 28029 Madrid, Spain.
Renata LinertováChronicity, Primary Healthcare and Health Promotion Research Network (Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 28029 Madrid, Spain.ORCID 0000-0002-0138-9252
Lidia García-PérezChronicity, Primary Healthcare and Health Promotion Research Network (Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 28029 Madrid, Spain.ORCID 0000-0002-5626-8116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two vaccines against rotavirus diseases, Rotarix

Indexed as

Cost-Benefit AnalysisQuality-Adjusted Life YearsRotavirus InfectionsRotavirus VaccinesVaccinationVaccines, AttenuatedBudgetsChild, PreschoolHumansInfantInfant, NewbornMarkov ChainsRotavirusSpainRIX4414 vaccineRotaTeqRotavirus VaccinesVaccines, Attenuatedbudget impactcost-effectivenesscost–utilityeconomic evaluationMarkov modelrotavirus vaccine

Identifiers

PMID39205168
PMCPMC11360725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.